- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Poly IC
Total 1412 results
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
University Medical Center GroningenAbbVie; Dutch Cancer SocietyWithdrawn
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital and other collaboratorsCompletedEpithelial Ovarian CancerKorea, Republic of
-
Zhongda HospitalCompleted
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
Grupo Español de Investigación en Cáncer de OvarioClovis Oncology, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
Samsung Medical CenterCompleted
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
National Taiwan University HospitalAstraZenecaRecruiting
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Gruppo Oncologico del Nord-OvestRecruitingHead and Neck Squamous Cell CarcinomaItaly
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
National Cancer Institute (NCI)RecruitingLung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial CancerUnited States
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
BayerGlaxoSmithKlineTerminatedOvarian Cancer | Advanced Solid Tumors (Excluding Prostate Cancer)United States
-
Sheba Medical CenterCompleted
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
PfizerMedivation, Inc.Completed
-
AstraZenecaParexelApproved for marketing
-
Medical University of South CarolinaTerminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...RecruitingColorectal Cancer | Pancreatic CancerUnited States
-
Nina BhardwajCompletedSolid TumorsUnited States
-
PCI Biotech ASCompletedHealthy VolunteerUnited Kingdom
-
Stemline Therapeutics, Inc.CompletedGlioblastoma Multiforme | Adult Brain GlioblastomaUnited States
-
Ahmad Mustafa Mohamed MetwalleyIbn Sina HospitalCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University; Florida State UniversityWithdrawnIncreasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With MenHepatitis A | Meningitis | HPV - Anogenital Human Papilloma Virus Infection
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Tianjin Huanhu HospitalRecruiting
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
PfizerTerminated
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of MiamiGlaxoSmithKlineNot yet recruiting